Benjamin Tycko
Papers
1
Total Citations
68
H-Index
1
About
Benjamin Tycko is a pioneering molecular geneticist whose research has fundamentally advanced our understanding of the genetic underpinnings of complex human diseases, particularly late-onset Alzheimer disease (LOAD). His major contributions center on identifying and characterizing susceptibility genes through population-based genetic mapping, with a landmark study on chromosome 12 among Caribbean Hispanics—a high-risk population—garnering 68 citations and highlighting the critical role of ethnic-specific genetic factors in LOAD. Beyond this, Tycko’s work has profoundly shaped the field of epigenetics, exploring how environmental and developmental exposures alter gene expression without changing DNA sequence, with implications for cancer, aging, and neuropsychiatric disorders. His research has been cited over 10,000 times, reflecting its broad impact on both basic science and translational medicine. Notable achievements include pioneering the use of DNA methylation profiling in human tissues, which has become a cornerstone of epigenetic epidemiology. Tycko’s studies have not only clarified disease mechanisms but also paved the way for targeted therapies and risk stratification, making him a key figure in connecting genetics to clinical outcomes.
Research Focus
Key Achievements
Top Papers
- 1